Evidence map›Paper›PMID 42797397›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Representative Conformational Sampling for Chiroptical Analysis of the Flexible Dopamine Agonist Rotigotine.

Yi-Xuan Li, Xiao-Li Zhou, Jing-Wen Xu, Chen Zhao, You-Yang Li, Hai-You Zhao, Liang-Peng Li, Xin-Xin Tan, Yu-Xiang Zhang, Bei-Bei Yang and 2 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yi-Xuan LiState Key Laboratory of Digestive Health, Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Xiao-Li ZhouState Key Laboratory of Drug Regulatory Science, National Institutes for Drug Control, Beijing 102629, China.ORCID 0000-0002-3411-4335
Jing-Wen XuState Key Laboratory of Drug Regulatory Science, National Institutes for Drug Control, Beijing 102629, China.
Chen ZhaoState Key Laboratory of Digestive Health, Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
You-Yang LiState Key Laboratory of Drug Regulatory Science, National Institutes for Drug Control, Beijing 102629, China.
Hai-You ZhaoState Key Laboratory of Digestive Health, Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Liang-Peng LiState Key Laboratory of Digestive Health, Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Xin-Xin TanState Key Laboratory of Digestive Health, Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Yu-Xiang ZhangState Key Laboratory of Digestive Health, Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Bei-Bei YangState Key Laboratory of Digestive Health, Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Li LiState Key Laboratory of Digestive Health, Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.ORCID 0000-0002-9496-2280
Li-Hui YinState Key Laboratory of Drug Regulatory Science, National Institutes for Drug Control, Beijing 102629, China.ORCID 0009-0005-3455-0216

Funding

State Key Laboratory of Drug Regulatory Science Project 2025SKLDRS0313
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

conformational analysiselectronic circular dichroismflexible moleculesoptical rotatory dispersionrotigotinetime-dependent density functional theoryvibrational circular dichroism

Identifiers

PMID42797397
PMCPMC13610727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.